DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)

Condition:   Hiv Intervention:   Drug: Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO] Sponsors:   University Hospital, Caen;   Merck Sharp & Dohme LLC Not yet recruiting

Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials